Home / Universität / Universitätskliniken / Universitätsklinik für Innere Medizin / Publikationen
Universitätsklinik für Innere Medizin

Publikationen

  1. 2020

    • Zeitschriftenartikel

      • Anwar, M., Fritze, R., Base, E., Wasserscheid, T., Wolfram, N., Koinig, H., Hackner, K., Lambers, C., Schweiger, T., Errhalt, P. & Hoda, M.A., 2020. Infraglottic versus supraglottic jet-ventilation for endobronchial ultrasound-guided transbronchial needle aspiration: A randomised controlled trial. European journal of anaesthesiology.

      • Auer, J. & Lamm, G., 2020. Ticagrelor with or without Aspirin after PCI. The New England journal of medicine, 382(11), S.1075-1076.

      • Behr, J., Gunther, A., Bonella, F., Dinkel, J., Fink, L., Geiser, T., Geissler, K., Glaser, S., Handzhiev, S., Jonigk, D., Koschel, D., Kreuter, M., Leuschner, G., Markart, P., Prasse, A., Schonfeld, N., Schupp, J.C., Sitter, H., Muller-Quernheim, J. & Costabel, U., 2020. S2K-Leitlinie zur Diagnostik der idiopathischen Lungenfibrose. Pneumologie.

      • Bruestle, K., Hackner, K., Kreye, G. & Heidecker, B., 2020. Autoimmunity in Acute Myocarditis: How Immunopathogenesis Steers New Directions for Diagnosis and Treatment. Current cardiology reports, 22(5), S.28.

      • Fastner, G., Sedlmayer, F., Widder, J., Metz, M., Geinitz, H., Kapp, K., Fesl, C., Solkner, L., Greil, R., Jakesz, R., Kwasny, W., Heck, D., Bjelic-Radisic, V., Balic, M., Stoger, H., Wieder, U., Zwrtek, R., Semmler, D., Horvath, W., Melbinger-Zeinitzer, E., Wiesholzer, M., Wette, V. & Gnant, M., 2020. Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial. European journal of cancer, 127, S.12-20.

      • Fazekas-Singer, J., Singer, J. & Jensen-Jarolim, E., 2020. Precision medicine in clinical oncology: the journey from IgG antibody to IgE. Current opinion in allergy and clinical immunology, 20(3), S.282-289.

      • Flick, H., Arns, B.-M., Bolitschek, J., Bucher, B., Cima, K., Gingrich, E., Handzhiev, S., Hochmair, M., Horak, F., Idzko, M., Jaksch, P., Kovacs, G., Kropfmüller, R., Lamprecht, B., Löffler-Ragg, J., Meilinger, M., Olschewski, H., Pfleger, A., Puchner, B., Puelacher, C., Prior, C., Rodriguez, P., Salzer, H., Schenk, P., Schindler, O., Stelzmüller, I., Strenger, V., Täubl, H., Urban, M., Wagner, M., Wimberger, F., Zacharasiewicz, A., Zwick, R.Harun & Eber, E., 2020. Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) : Statement of the Austrian Society of Pneumology (ASP). Wiener klinische Wochenschrift.

      • Gelbenegger, G., Schoergenhofer, C., Derhaschnig, U., Buchtele, N., Sillaber, C., Fillitz, M., Schenk, T.M., D'Sa, S., Cartwright, R., Gilbert, J.C., Jilma, B. & Jaeger, U., 2020. Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program. Blood advances, 4(6), S.997-1005.

      • Ghanim, B., Rosenmayr, A., Stockhammer, P., Vogl, M., Celik, A., Bas, A., Kurul, I.Cuneyt, Akyurek, N., Varga, A., Plönes, T., Bankfalvi, A., Hager, T., Schuler, M., Hackner, K., Errhalt, P., Scheed, A., Seebacher, G., Hegedus, B., Stubenberger, E. & Aigner, C., 2020. Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition. Scientific Reports, 10(1), S.5784.

      • Jäger, E.Maria, Filipits, M., Glechner, A., Zwickl-Traxler, E., Schmoranzer, G., Pecherstorfer, M. & Kreye, G., 2020. Retrospective analysis of the prevalence of specialised palliative care services for patients with metastatic breast cancer. ESMO open, 5(5).

      • Kleinsasser, A., Treml, B., Burtscher, J., Podolsky, A. & Burtscher, M., 2020. Oxygen availability in a HAPE-positive and a HAPE-negative woman before and during a visit to 3480 meters. Respiratory physiology & neurobiology, S.103513.

      • Klösch, M., Deix, G. & von Reibnitz, C., 2020. Nähe vermitteln in Zeiten der Distanz: Digitale Angebote fur Trauerfeiern und Bestattungen unter COVID-19-Bedingungen. Procare : das fortbildungsmagazin fur pflegeberufe, 25(4), S.14-16.

      • Krall, N., Sehlke, R., Taubert, C., Alt, I., Rohrer, F., Fuchs, E., Vilagos, B., Schumacher, M., Maurer, D., Hackner, K., Lafleur, J., Hefler, L., Minichsdorfer, C., Fuereder, T. & Vladimer, G., 2020. Towards patient-centric drug discovery: Drug action in malignant pleural effusions and ascites using high content imaging and deep learning. Journal of Clinical Oncology, 38, S.e21633-e21633.

      • Kreye, G., Heidecker, B. & Masel, E.K., 2020. The top ten things that must be known about end of life therapy in patients with advanced cancer. memo - Magazine of European Medical Oncology, 13(1), S.88-92.

      • Kutschera, M., Waldhor, T., Grochenig, H.Peter, Haas, T., Wenzl, H., Steiner, P., Koch, R., Feichtenschlager, T., Eckhardt, G., Mayer, A., Kirchgatterer, A., Ludwiczek, O., Platzer, R., Papay, P., Gartner, J., Fuchssteiner, H., Peters, P.-G., Reicht, G., Moser, G., Dejaco, C., Vogelsang, H., Primas, C., Novacek, G. & Miehsler, W., 2020. Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease. United European gastroenterology journal, S.2050640620946874.

      • Petzer, A.L., Sperr, W.R., Buxhofer-Ausch, V., Sliwa, T., Schmidt, S., Greil, R., Wölfler, A., Pichler, P., Dormann, C., Burgstaller, S., Tinchon, C., Lang, A., Goebel, F., Uthman, S., Muenchmeier, N. & Valent, P., 2020. A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT study. Wiener klinische Wochenschrift.

      • Petzl, A., Derndorfer, M., Kollias, G., Moroka, K., Aichinger, J., Purerfellner, H. & Martinek, M., 2020. Cerebral thromboembolic risk in atrial fibrillation ablation: a direct comparison of vitamin K antagonists versus non-vitamin K-dependent oral anticoagulants. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing.

      • Podar, K., Shah, J., Chari, A., Richardson, P.G. & Jagannath, S., 2020. Selinexor for the treatment of multiple myeloma. Expert opinion on pharmacotherapy, S.1-10.

      • Poelzl, G., Fetz, B., Altenberger, J., Fritsch, M., Auer, J., Stachl, E., Böhmer, A., Frauendorfer, H., Ebner, C., Geyrhofer, F., Potz, S., Prim, A., Alber, H., de Grandis, R., Drack, C., Hulsmann, M., Working, G.Heart Fail, Cardiological, Athe Workin & for, C.Care Perso, 2020. Heart failure disease management programs in Austria 2019 : A systematic survey of the Heart Failure Working Group and the Working Group for Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology. Wiener klinische Wochenschrift.

      • Reich, B., Benzer, W., Harpf, H., Hofmann, P., Mayr, K., Ocenasek, H., Podolsky, A., Pokan, R., Porodko, M., Puelacher, C., Sareban, M., Traninger, H., Ziegelmeyer, W. & Niebauer, J., 2020. Efficacy of extended, comprehensive outpatient cardiac rehabilitation on cardiovascular risk factors: A nationwide registry. European journal of preventive cardiology.

      • Riedl, J.Michael, Posch, F., Prager, G., Eisterer, W., Oehler, L., Sliwa, T., Wilthoner, K., Petzer, A., Pichler, P., Hubmann, E., Winder, T., Burgstaller, S., Korger, M., Andel, J., Greil, R., Neumann, H.-J., Pecherstorfer, M., Philipp-Abbrederis, K., Djanani, A., Gruenberger, B., Laengle, F., Woll, E. & Gerger, A., 2020. The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study. Therapeutic advances in medical oncology, 12, S.1758835919900872.

      • Schukro, C., Santer, D., Prenner, G., Stuhlinger, M., Martinek, M., Teubl, A., Moertl, D., Schwarz, S., Nürnberg, M., Fiedler, L., Hatala, R. & Khazen, C., 2020. State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy. Clinical cardiology.

      • Smiljkovic, D., Kiss, R., Lupinek, C., Hoermann, G., Greiner, G., Witzeneder, N., Krajnik, G., Trautinger, F., Vrtala, S., Mittermann, I., Kundi, M., Jilma, B., Valenta, R., Sperr, W.R. & Valent, P., 2020. Microarray-based Detection of Allergen-Reactive IgE in Patients with Mastocytosis. The journal of allergy and clinical immunology. In practice.

      • Tobudic, S., Prager, I., Kussmann, M., Obermuller, M., Ursli, M., Zeitlinger, M., Wiesholzer, M., Burgmann, H., Poeppl, W. & Reznicek, G., 2020. Compatibility of aztreonam in four commercial peritoneal dialysis fluids. Scientific reports, 10(1), S.1788.

      • Tripolt, N.J., Kolesnik, E., Pferschy, P.N., Verheyen, N., Ablasser, K., Sailer, S., Alber, H., Berger, R., Kaulfersch, C., Leitner, K., Lichtenauer, M., Mader, A., Moertl, D., Oulhaj, A., Reiter, C., Rieder, T., Saely, C.H., Siller-Matula, J., Weidinger, F., Zechner, P.M., von Lewinski, D., Sourij, H. & group, Estudy, 2020. Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial. American heart journal, 221, S.39-47.

      • Wagner, G., Stollenwerk, H.Karolina, Klerings, I., Pecherstorfer, M., Gartlehner, G. & Singer, J., 2020. Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review. OncoImmunology, 9(1), S.1774314.

      • Zwickl, H., Hackner, K., Köfeler, H., Krzizek, E.-C., Muqaku, B., Pils, D., Scharnagl, H., Solheim, T.S., Zwickl-Traxler, E. & Pecherstorfer, M., 2020. Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia. Frontiers in Oncology, 10(1262).

    • Buchkapitel

      • Giese, R. & Hackner, K., 2020. Canine Olfaction. In J. Beauchamp, Davis, C., & Pleil, J. (Hrsg.): Breathborne Biomarkers and the Human Volatilome. Elsevier.

    • Konferenzbeitrag

      • Ludwig, H., Sormann, S., Zojer, N., Andel, J., Hartmann, B.L., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Woll, E., Ruckser, R., Bozic, B., Krauth, M.-T., Petzer, A., Schmitt, C.A., Machherndl-Spandl, S., Agis, H., Fillitz, M., Paiva, B. & Greil, R., 2020. Poster: Carfilzomib in combination with either Rd or Td overcomes the negative impact of HR cytogenetics in NDMM. Interim efficacy analysis of combined data of KRd vs. KTd followed by K maintenance or control. In 25th Congress of the European Hematology Association (EHA). COVID-19 Online.

    • Andere wissenschaftliche Beiträge

      • Podar, K., 2020. Stellenwert der autologen Stammzelltransplantation beim multiplen Myelom. JATROS Hämatologie & Onkologie, (2), S.6-9.

      • Vallet, S., 2020. Kombinationstherapien in der Behandlung urogenitaler Tumoren. JATROS Hämatologie & Onkologie, (2).

  2. 2019

    • Zeitschriftenartikel

      • Bauer, W.Rudolf, Lau, D.H., Wollmann, C.Georg, McGavigan, A., Mansourati, J., Reiter, T., Fromer, S., Ladd, M.E. & Quick, H.H., 2019. Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla. Scientific reports, 9(1), S.18243.

      • Berger, R., Hulsmann, M., Moertl, D. & Polzl, G., 2019. Curriculum heart failure : Task force curriculum heart failure of the working group on heart failure of the Austrian Cardiological Society. Wiener klinische Wochenschrift, 131, S.299-312.

      • Chari, A., Vogl, D.T., Gavriatopoulou, M., Nooka, A.K., Yee, A.J., Huff, C.A., Moreau, P., Dingli, D., Cole, C., Lonial, S., Dimopoulos, M., A. Stewart, K., Richter, J., Vij, R., Tuchman, S., Raab, M.S., Weisel, K.C., Delforge, M., Cornell, R.F., Kaminetzky, D., Hoffman, J.E., Costa, L.J., Parker, T.L., Levy, M., Schreder, M., Meuleman, N., Frenzel, L., Mohty, M., Choquet, S., Schiller, G., Comenzo, R.L., Engelhardt, M., Illmer, T., Vlummens, P., Doyen, C., Facon, T., Karlin, L., Perrot, A., Podar, K., Kauffman, M.G., Shacham, S., Li, L., Tang, S., Picklesimer, C., Saint-Martin, J.-R., Crochiere, M., Chang, H., Parekh, S., Landesman, Y., Shah, J., Richardson, P.G. & Jagannath, S., 2019. Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. The New England journal of medicine, 381, S.727-738.

      • Eder, M., Strassl, R., Beinhardt, S., Stattermayer, A.Friedrich, Kozbial, K., Lagler, H., Holzmann, H., Trauner, M. & Hofer, H., 2019. High seroprevalence of anti-Hepatitis E antibodies in Austrian patients with autoimmune hepatitis. Liver International, 39(4), S.640-645.

      • Egle, A., Melchardt, T., Obrtlikova, P., Smolej, L., Kozak, T., Steurer, M., Andel, J., Burgstaller, S., Mikuskova, E., Gercheva, L., Nosslinger, T., Papajik, T., Ladicka, M., Girschikofsky, M., Hrubisko, M., Jager, U., Voskova, D., Pecherstorfer, M., Kralikova, E., Burcoveanu, C., Spasov, E., Petzer, A., Mihaylov, G., Raynov, J., Oexle, H., Zabernigg, A., Flochova, E., Palasthy, S., Stehlikova, O., Doubek, M., Altenhofer, P., Weiss, L., Magnes, T., Pleyer, L., Klingler, A., Mayer, J. & Greil, R., 2019. Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial. Cancer medicine, 8, S.1401-1405.

      • Flamm, S., K. Reddy, R., Zadeikis, N., Hassanein, T., Bacon, B.R., Maieron, A., Zeuzem, S., Bourliere, M., Calleja, J.L., Kosloski, M.P., Oberoi, R.K., Lin, C.-W., Yu, Y., Lovell, S., Semizarov, D. & Mensa, F.J., 2019. Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 17, S.527-535 e6.

      • Grochenig, H.Peter, Waldhor, T., Haas, T., Wenzl, H., Steiner, P., Koch, R., Feichtenschlager, T., Eckhardt, G., Mayer, A., Kirchgatterer, A., Ludwiczek, O., Platzer, R., Papay, P., Gartner, J., Fuchssteiner, H., Miehsler, W., Peters, P.-G., Reicht, G., Kutschera, M., Dejaco, C., Vogelsang, H., Novacek, G. & Austrian, I.B.D.Stud, 2019. Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease. European journal of gastroenterology & hepatology, 31(10), S.1211-1219.

      • Gschwantler, M., Bamberger, T., Graziadei, I., Maieron, A., Katalinic, N. & Stauber, R., 2019. Burden of disease in patients with chronic hepatitis C in the Austrian REAL study. Wiener klinische Wochenschrift, 131(1-2), S.8-16.

      • Hackner, K., Errhalt, P. & Handzhiev, S., 2019. Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion. Therapeutic advances in medical oncology, 11, S.1758835919850341.

      • Hammer, A., Moertl, D., Schlager, O., Matschuck, M., Seidinger, D., Koppensteiner, R. & Steiner, S., 2019. Effects of n-3 PUFA on endothelial function in patients with peripheral arterial disease: a randomised, placebo-controlled, double-blind trial. The British journal of nutrition, 122(6), S.698-706.

      • Kussmann, M., Ferth, A., Obermuller, M., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H., Poeppl, W. & Reznicek, G., 2019. Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions. Scientific reports, 9, S.6512.

      • Li, S., Vallet, S., Sacco, A., Roccaro, A., Lentzsch, S. & Podar, K., 2019. Targeting transcription factors in multiple myeloma: evolving therapeutic strategies. Expert opinion on investigational drugs, 28, S.445-462.

      • Lind, J., Czernilofsky, F., Vallet, S. & Podar, K., 2019. Emerging protein kinase inhibitors for the treatment of multiple myeloma. Expert opinion on emerging drugs, 24, S.133-152.

      • Monino-Romero, S., Lexmond, W.S., Singer, J., Bannert, C., Amoah, A.S., Yazdanbakhsh, M., Boakye, D.A., Jensen-Jarolim, E., Fiebiger, E. & Szepfalusi, Z., 2019. Soluble FcvarepsilonRI: A biomarker for IgE-mediated diseases. Allergy, 74, S.1381-1384.

      • Odeneg, T., Ebner, C., Moertl, D., Keller, H., Dirninger, A., Stix, G., Foger, B., Grimm, G., Steinwender, C., Gebetsberger, F., Stuhlinger, M., Mastnak, B., Haider, C., Manninger, M. & Scherr, D., 2019. Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 18, S.75-83.

      • Pfisterer, N., Riedl, F., Pachofszky, T., Gschwantler, M., Konig, K., Schuster, B., Mandorfer, M., Gessl, I., Illiasch, C., Fuchs, E.-M., Unger, L., Dolak, W., Maieron, A., Kramer, L., Madl, C., Trauner, M. & Reiberger, T., 2019. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study. Liver International, 39(2), S.290-298.

      • Riedl, J., Posch, F., Prager, G., Eisterer, W., Ohler, L., Thamer, S., Wilthoner, K., Petzer, A., Pichler, P., Hubmann, E., Winder, T., Burgstaller, S., Korger, M., Andel, J., Greil, R., Pecherstorfer, M., Philipp-Abbrederis, K., Djanani, A., Gruenberger, B., Langle, F., Woll, E. & Gerger, A., 2019. The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study. Annals of oncology: official journal of the European Society for Medical Oncology, 30 Suppl 4, S.iv78.

      • Schwarzer, R., Reiberger, T., Mandorfer, M., Kivaranovic, D., Hametner, S., Hametner, S., Paternostro, R., Scheiner, B., Schneeweiss-Friedl, J., Trauner, M., Schoefl, R. & Maieron, A., 2019. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis. Journal of gastroenterology.

      • Senoner, T., Barbieri, F., Semmler, G., Adukauskaite, A., Rubatscher, A., Schgor, W., Stuhlinger, M., Bauer, A., Pfeifer, B.Erich, Fiedler, L., Roithinger, F.Xaver, Hintringer, F., Suessenbacher, A., Wollmann, C.Georg & Dichtl, W., 2019. Long-term performance of an atrial lead capable of accelerometer based detection of cardiac contractility in patients receiving cardiac resynchronisation therapy. PloS one, 14, S.e0222269.

      • Singer, J., Achatz-Straussberger, G., Bentley-Lukschal, A., Fazekas-Singer, J., Achatz, G., Karagiannis, S.N. & Jensen-Jarolim, E., 2019. AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice. The World Allergy Organization journal, 12, S.100044.

      • Vallet, S., Fan, F., Malvestiti, S., Pecherstorfer, M., Sattler, M., Schneeweiss, A., Schulze-Bergkamen, H., Opferman, J.T., Cardone, M.H., Jager, D. & Podar, K., 2019. Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer. Breast cancer research and treatment, 173, S.585-596.

      • Wagner, G., Haumer, M., Poelzl, G., Wiedemann, D., Kliegel, A., Ullrich, R., Gartlehner, G., Zuckermann, A., Muller, L., Mayr, H. & Moertl, D., 2019. A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation. BMC cardiovascular disorders, 19(1), S.302.

      • Wagner, G., Steiner, S., Gartlehner, G., Arfsten, H., Wildner, B., Mayr, H. & Moertl, D., 2019. Comparison of transcatheter aortic valve implantation with other approaches to treat aortic valve stenosis: a systematic review and meta-analysis. Systematic reviews, 8(1), S.44.

      • Zwickl, H., Zwickl-Traxler, E. & Pecherstorfer, M., 2019. Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives. Frontiers in oncology, 9, S.1409.

    • Konferenzbeitrag

      • Fan, F., Malvestiti, S., Shen, Y., Morelli, E., Mishima, Y., Seckinger, A., Hose, D., Bakiri, L., Vallet, S., Sattler, M., Roccaro, A.M., Goldschmidt, H., Percherstorfer, M., Sun, C., Hu, Y., Wagner, E.F., Tassone, P., Ghobrial, I.M., Jaeger, D. & Podar, K., 2019. Multiple Myeloma Pathogenesis: The Role of Junb in Bone Marrow Angiogenesis. In American Society of Hematology, 61th Annual Meeting, scientific session. Orlando, FL.

      • Grech, C., Hackner, K., Buder, A., Strieder, M., Hochmair, M.J., Filipits, M. & Errhalt, P., 2019. Analysis of circulating tumor DNA in paired plasma and sputum samples of EGFR-mutated NSCLC patients. In European society for medical oncology. Barcelona.

      • Hackner, K., Javaheri, S., Gerges, C., Kneussl, M.P., Errhalt, P., Gerges, M., Maurer, M. & Lang, I.M., 2019. Sleep-Disordered Breathing and Hypoxemia in Treatment-Naïve Patients with Chronic Thromboembolic Pulmonary Hypertension. In American Thoracic Society. Dallas, S. A1994.

      • Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E.F., Sattler, M., Pecherstorfer, M. & Podar, K., 2019. Poster: Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy. In 17th International Myeloma Workshop. Boston.

      • Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Sattler, M., Bakiri, L., Wagner, E.F., Percherstorfer, M. & Podar, K., 2019. Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs for Multiple Myelioma Therapy. In American Society of Hematology, 61th Annual Meeting, scientific session. Orlando, FL.

      • Ludwig, H., Sormann, S., Zojer, N., Andel, J., Hartmann, B.L., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Woll, E., Ruckser, R., Bozic, B., Krauth, M.-T., Petzer, A., Schmitt, C.A., Machherndl-Spandl, S., Agis, H., Paiva, B. & Greil, R., 2019. Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Ef. In American Society of Hematology, 61th Annual Meeting, scientific session. Orlando, FL.

      • Pleyer, L., Pfeilstocker, M., Stauder, R., Heibl, S., Sill, H., Girschikofsky, M., Stampfl-Mattersberger, M., Tinchon, C., Petzer, A., Schmitt, C.A., Vallet, S., Mandac, I., Geissler, K., Sperr, W.R., Leisch, M., Egle, A., Melchardt, T., Fusinato, J., Piringer, G., Zebisch, A., Machherndl-Spandl, S., Wolf, D., Keil, F. & Greil, R., 2019. Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group. In American Society of Hematology, 61th Annual Meeting, scientific session. Orlando, FL.

      • Podar, K., 2019. Multiples Myelom II. In DGHO, OeGHO, SGMO & SGH 2019 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie). Berlin.

      • Podar, K., 2019. Präsentation: Klinisch relevante Arzneimittelinteraktionen im Multiplen Myelom. In Hämatologie im Wandel der Zeit . 28.-29.06.2019. Wien.

      • Podar, K., 2019. Präsentation: Stellenwert der Autologen Stammzelltransplantation beim Multiplen Myelom. In 9. Niederösterreichischer Onkologietag. Krems.

      • Podar, K., 2019. Presentation: Targeting transcription factors for cancer therapy: evolving therapeutic strategies . In 9. Niederösterreichischer Onkologietag. Krems.

      • Stättermayer, M.-S., Riedl, F., Bernhofer, S., Stättermayer, A., Mayer, A. & Maieron, A., 2019. Poster: Prospective evaluation for gastrointestinal bleedings at the University Hospital St. Pölten – one year of follow-up. In ÖGGH-Jahrestagung.

      • Stättermayer, M.-S., Riedl, F., Bernhofer, S., Stättermayer, A., Mayer, A. & Maieron, A., 2019. Poster: Prospective evaluation of blood transfusion management in patients with gastrointestinal bleedings at the University Hospital St. Pölten. In ÖGGH-Jahrestagung.

  3. 2018

    • Zeitschriftenartikel

      • Balber, T., Singer, J., Berroteran-Infante, N., Dumanic, M., Fetty, L., Fazekas-Singer, J., Vraka, C., Nics, L., Bergmann, M., Pallitsch, K., Spreitzer, H., Wadsak, W., Hacker, M., Jensen-Jarolim, E., Viernstein, H. & Mitterhauser, M., 2018. Preclinical In Vitro and In Vivo Evaluation of [(18)F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer. Contrast Media & Molecular Imaging, 2018, S.1269830.

      • Beinhardt, S., Al-Zoairy, R., Kozbial, K., Stattermayer, A.F., Maieron, A., Stauber, R., Strasser, M., Zoller, H., Graziadei, I., Rasoul-Rockenschaub, S., Trauner, M., Ferenci, P. & Hofer, H., 2018. Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation. Liver International, 38, S.1188-1197.

      • Breitkreutz, I., Podar, K., Figueroa-Vazquez, V., Wilhelm, S., Hayden, P.J., Anderson, K.C. & Raab, M.S., 2018. The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma. Annals of Hematology, 97, S.839-849.

      • Buder, A., Hochmair, M.J., Schwab, S., Bundalo, T., Schenk, P., Errhalt, P., Mikes, R.E., Absenger, G., Patocka, K., Baumgartner, B., Setinek, U., Burghuber, O.C., Prosch, H., Pirker, R. & Filipits, M., 2018. Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC. Journal of Thoracic Oncology, 13, S.821-830.

      • Fazekas-Singer, J., Singer, J., Ilieva, K.M., Matz, M., Herrmann, I., Spillner, E., Karagiannis, S.N. & Jensen-Jarolim, E., 2018. AllergoOncology: Generating a canine anticancer IgE against the epidermal growth factor receptor. Journal of Allergy and Clinical Immunology, 142, S.973-976.e11.

      • Hintermair, S., Zwickl-Traxler, E., Pecherstorfer, M. & Singer, J., 2018. Evaluation of vascular events in patients with myeloproliferative syndromes and mutations of either the januskinase-2 or calreticulin gene at the university hospital Krems from 2008 to 2015. Oncotarget, 9, S.8450-8462.

      • Kozbial, K., Moser, S., Al-Zoairy, R., Schwarzer, R., Datz, C., Stauber, R., Laferl, H., Strasser, M., Beinhardt, S., Stattermayer, A.F., Gschwantler, M., Zoller, H., Maieron, A., Graziadei, I., Trauner, M., Steindl-Munda, P., Hofer, H. & Ferenci, P., 2018. Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment. Liver International, 38, S.1028-1035.

      • Krammel, M., Schnaubelt, S., Weidenauer, D., Winnisch, M., Steininger, M., Eichelter, J., Hamp, T., van Tulder, R.Henricus & Sulzgruber, P., 2018. Gender and age-specific aspects of awareness and knowledge in basic life support. PLoS One, 13, S.e0198918.

      • Kreye, G., Masel, E.K., Hackner, K., Stich, B. & Nauck, F., 2018. Methadone as anticancer treatment: hype, hope, or hazard? : A series of case reports and a short review of the current literature and recommendations of the societies. Wiener Medizinische Wochenschrift, 168, S.159-167.

      • Kussmann, M., Hauer, S., Pichler, P., Reznicek, G., Burgmann, H., Poeppl, W., Zeitlinger, M. & Wiesholzer, M., 2018. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases, 37, S.1091-1098.

      • Masel, E.K. & Kreye, G., 2018. Demystification of palliative care: what palliative care teams don't want you to think about them. memo - Magazine of European Medical Oncology, 11, S.193-195.

      • Miehsler, W., Dejaco, C., Grochenig, H.-P., Fuchssteiner, H., Hogenauer, C., Kazemi-Shirazi, L., Maier, H., Mayer, A., Moschen, A., Reinisch, W., Petritsch, W., Platzer, R., Steiner, P., Tilg, H., Vogelsang, H., Wenzl, H. & Novacek, G., 2018. Zweiter österreichischer Konsensus zur sicheren Anwendung von anti-TNF-alpha-Antikörpern bei chronisch-entzündlichen Darmerkrankungen. Zeitschrift fur Gastroenterologie, 56(3), S.275-302.

      • Neuhold, U., Rohla, M., Glaser, F. & Mihalcz, A., 2018. Eine seltene Rhythmusstörung. Journal für Kardiologie, 25, S.30-33.

      • Odeneg, T., Ebner, C., Moertl, D., Keller, H., Dirninger, A., Stix, G., Foger, B., Grimm, G., Steinwender, C., Gebetsberger, F., Stuhlinger, M., Mastnak, B., Haider, C., Manninger, M. & Scherr, D., 2018. Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry. European Journal of Cardiovascular Nursing , S.1474515118790365.

      • Pirich, T., Zwickl-Traxler, E., Pecherstorfer, M. & Singer, J., 2018. Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study. Oncotarget, 9, S.29944-29956.

      • Podar, K., 2018. Choosing an appropriate salvage therapy for a patient with multiple myeloma. Expert Opinion on Pharmacotherapy, 19, S.1511-1516.

      • Poeppl, W., Rainer-Harbach, E., Kussmann, M., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H. & Reznicek, G., 2018. Compatibility of linezolid with commercial peritoneal dialysis solutions. American Journal of Health-System Pharmacy, 75, S.1467-1477.

      • Rohla, M., Tscharre, M., Huber, K. & Weiss, T.W., 2018. Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA) : A cluster-randomized trial. Wiener klinische Wochenschrift, 130, S.698-706.

      • Sponder, M., Khazen, C., Dichtl, W., Fiedler, L., Moertl, D., Teubl, A., Steinwender, C., Martinek, M., Nurnberg, M., Dalos, D., Kastner, J. & Schukro, C., 2018. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry. European Journal of Internal Medicine, 48, S.64-68.

      • Steger, G.G., Dominguez, A., Dobrovolskaya, N., Giotta, F., Tubiana-Mathieu, N., Pecherstorfer, M., Ardizzoia, A., Blasinska-Morawiec, M., Espinosa, E. & Villanova, G., 2018. Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study. Clinical Breast Cancer, 18, S.e41-e47.

      • Steger, G.G., Dominguez, A., Dobrovolskaya, N., Giotta, F., Tubiana-Mathieu, N., Pecherstorfer, M., Ardizzoia, A., Blasinska-Morawiec, M., Espinosa, E. & Villanova, G., 2018. Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study. Clinical breast cancer, 18(1), S.e41-e47.

      • Strieder, M., Pecherstorfer, M. & Kreye, G., 2018. Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature. Wiener Medizinische Wochenschrift, 168, S.333-343.

      • Vallet, S., Fan, F., Malvestiti, S., Pecherstorfer, M., Sattler, M., Schneeweiss, A., Schulze-Bergkamen, H., Opferman, J.T., Cardone, M.H., Jager, D. & Podar, K., 2018. Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer. Breast Cancer Research and Treatment.

      • Vallet, S., Filzmoser, J.M., Pecherstorfer, M. & Podar, K., 2018. Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies. Pharmaceutics, 10, S.202.

      • Vallet, S., Hoyle, N.R., Kyle, R.A., Podar, K. & Pecherstorfer, M., 2018. A role for bone turnover markers beta-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma. Leukemia & Lymphoma, 59, S.2431-2438.

      • Vychytil, A., Herzog, R., Probst, P., Ribitsch, W., Lhotta, K., Machold-Fabrizii, V., Wiesholzer, M., Kaufmann, M., Salmhofer, H., Windpessl, M., Rosenkranz, A.R., Oberbauer, R., Konig, F., Kratochwill, K. & Aufricht, C., 2018. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health. Kidney International.

      • Wurm, R., Schrutka, L., Hammer, A., Moertl, D., Berger, R., Pavo, N., Lang, I.M., Goliasch, G., Huelsmann, M. & Distelmaier, K., 2018. Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure. European Journal of Clinical Investigation, 48, S.e12998.

    • Konferenzbeitrag

      • Malvestiti, S., Fan, F., Bashari, H.M., Morelli, E., Seckinger, A., Hose, D., Goldschmidt, H., Zoernig, I., Bakiri, L., Sattler, M., Vallet, S., Pecherstorfer, M., Wagner, E.F., Tassone, P., Jaeger, D. & Podar, K., 2018. Poster: Multiple myeloma pathogenesis: The role of JunB in bone marrow angiogenesis. In 23rd Congress of the European Hematology Association (EHA). Stockholm, Sweden.

      • Podar, K., 2018. Presentation: Transcription factors in multiple myeloma: new potential targets. In 4th Multiple Myeloma and related malignancies. Bari, Italy.

      • Podar, K., 2018. Therapiefortschritte – Hämato-Onkologie im Jahr 2018: Multiples Myelom. In 8. Niederösterreichischer Onkologietag. Krems.

    • Andere wissenschaftliche Beiträge

      • Podar, K., 2018. Immunmodulierende Medikamente bleiben essenzielle Basis der Therapie. JATROS Hämatologie & Onkologie, (5), S.41.

      • Podar, K., 2018. Teamwork gegen Krebs. Gesund leben in Niederösterreich, (6), S.30-32.

      • Vallet, S., 2018. Checkpointblockade beim metastasierten Urothelkarzinom. JATROS Hämatologie & Onkologie, (2).

  4. 2017

    • Zeitschriftenartikel

      • Auer, J., Verbrugge, F.H. & Lamm, G., 2017. What do small serum creatinine changes tell us about outcomes after acute myocardial infarction?. European Heart Journal: Acute Cardiovascular Care, S.2048872617728721.

      • Bhanot, H., Weisberg, E.L., Reddy, M.M., Nonami, A., Neuberg, D., Stone, R.M., Podar, K., Salgia, R., Griffin, J.D. & Sattler, M., 2017. Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming. Oncotarget, 8, S.67639-67650.

      • Fan, F., Bashari, M.H., Morelli, E., Tonon, G., Malvestiti, S., Vallet, S., Jarahian, M., Seckinger, A., Hose, D., Bakiri, L., Sun, C., Hu, Y., Ball, C.R., Glimm, H., Sattler, M., Goldschmidt, H., Wagner, E.F., Tassone, P., Jaeger, D. & Podar, K., 2017. The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment. Leukemia, 31, S.1570-1581.

      • Fazekas, J., Grunt, T.W., Jensen-Jarolim, E. & Singer, J., 2017. Long term storage in liquid nitrogen leads to only minor phenotypic and gene expression changes in the mammary carcinoma model cell line BT474. Oncotarget, 8, S.35076-35087.

      • Fazekas-Singer, J., Berroteran-Infante, N., Rami-Mark, C., Dumanic, M., Matz, M., Willmann, M., Andreae, F., Singer, J., Wadsak, W., Mitterhauser, M. & Jensen-Jarolim, E., 2017. Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials. Oncotarget, 8, S.83128-83141.

      • Giustino, G., Redfors, B., Brener, S.J., Kirtane, A.J., Genereux, P., Maehara, A., Dudek, D., Neunteufl, T., Metzger, D.C., Crowley, A., Mehran, R., Gibson, C.M. & Stone, G.W., 2017. Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. European Heart Journal: Acute Cardiovascular Care, S.2048872617719649.

      • Hackner, K. & Pleil, J., 2017. Canine olfaction as an alternative to analytical instruments for disease diagnosis: understanding 'dog personality' to achieve reproducible results. Journal of Breath Research, 11, S.012001.

      • Hackner, K., Errhalt, P. & Doll, T., 2017. Reply to Comment on 'Canine scent detection for the diagnosis of lung cancer in a screening-like situation'. Journal of Breath Research, 11, S.038002.

      • Hackner, K., Riegler, W., Handzhiev, S., Bauer, R., Veres, J., Speiser, M., Meisinger, K. & Errhalt, P., 2017. Fever after bronchoscopy: serum procalcitonin enables early diagnosis of post-interventional bacterial infection. BMC Pulmonary Medicine, 17, S.156.

      • Koller, L., Richter, B., Winter, M.P., Sulzgruber, P., Potolidis, C., Liebhart, F., Moertl, D., Berger, R., Goliasch, G., Lang, I., Wojta, J., Hulsmann, M. & Niessner, A., 2017. Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure. Journal of Clinical Lipidology, 11, S.178-184.

      • Kussmann, M., Baumann, A., Hauer, S., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H., Poeppl, W. & Reznicek, G., 2017. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. European Journal of Clinical Microbiology & Infectious Diseases, 36, S.2237-2242.

      • Lebherz-Eichinger, D., Tudor, B., Ankersmit, H.J., Reiter, T., Haas, M., Einwallner, E., Roth-Walter, F., Krenn, C.G. & Roth, G.A., 2017. Increased trefoil factor 2 levels in patients with chronic kidney disease. PLoS One, 12, S.e0174551.

      • Marek, S., Gamper, G., Reining, G., Bergmann, P., Mayr, H. & Kliegel, A., 2017. ECMO and cytokine removal for bridging to surgery in a patient with ischemic ventricular septal defect - a case report. The International Journal of Artificial Organs, 40, S.526-529.

      • Moertl, D., Altenberger, J., Bauer, N., Berent, R., Berger, R., Böhmer, A., Ebner, C., Fritsch, M., Geyrhofer, F., Huelsmann, M., Poelzl, G. & Stefenelli, T., 2017. Disease management programs in chronic heart failure : Position statement of the Heart Failure Working Group and the Working Group of the Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology. Wiener klinische Wochenschrift, 129, S.869-878.

      • Podar, K. & Jager, D., 2017. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma. Current Cancer Drug Targets, 17, S.782-805.

      • Podar, K. & Pecherstorfer, M., 2017. Current and developing synthetic pharmacotherapy for treating relapsed/refractory multiple myeloma. Expert Opinion on Pharmacotherapy, 18, S.1061-1079.

      • Reiberger, T., Puspok, A., Schoder, M., Baumann-Durchschein, F., Bucsics, T., Datz, C., Dolak, W., Ferlitsch, A., Finkenstedt, A., Graziadei, I., Hametner, S., Karnel, F., Krones, E., Maieron, A., Mandorfer, M., Peck-Radosavljevic, M., Rainer, F., Schwabl, P., Stadlbauer, V., Stauber, R., Tilg, H., Trauner, M., Zoller, H., Schofl, R. & Fickert, P., 2017. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wiener klinische Wochenschrift, 129, S.135-158.

      • Rosenberger, F., Wiskemann, J., Vallet, S., Haag, G.M., Schembri, E., Jager, D. & Grüllich, C., 2017. Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy-a controlled feasibility trial. Support Care Cancer, 25, S.3655-3664.

      • Sandhofer, M.J., Robak, O., Frank, H. & Kulnig, J., 2017. Vaccine hesitancy in Austria : A cross-sectional survey. Wiener klinische Wochenschrift, 129, S.59-64.

      • Vallet, S., Pecherstorfer, M. & Podar, K., 2017. Adoptive cell therapy in multiple Myeloma. Expert Opinion on Biological Therapy, 17, S.1511-1522.

      • Wiesholzer, M., Winter, A., Kussmann, M., Zeitlinger, M., Pichler, P., Burgmann, H., Reznicek, G. & Poeppl, W., 2017. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions. Peritoneal Dialysis International, 37, S.51-55.

      • Worel, N., Fritsch, G., Agis, H., Bohm, A., Engelich, G., Leitner, G.C., Geissler, K., Gleixner, K., Kalhs, P., Buxhofer-Ausch, V., Keil, F., Kopetzky, G., Mayr, V., Rabitsch, W., Reisner, R., Rosskopf, K., Ruckser, R., Zoghlami, C., Zojer, N. & Greinix, H.T., 2017. Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure. Journal of Clinical Apheresis, 32, S.224-234.

      • Zangrando, M.Maurizio, Böhmer, A. & Glaser, F., 2017. Kardiale Sarkoidose mit Normalisierung einer schwer reduzierten links- und rechtsventrikulären Pumpfunktion. Austrian Journal of Cardiology, 24, S.216-221.

  5. 2016

    • Zeitschriftenartikel

      • Bohn, B., Kerner, W., Seufert, J., Kempe, H.P., Jehle, P.M., Best, F., Fuchtenbusch, M., Knauerhase, A., Hofer, M., Rosenbauer, J. & Holl, R.W., 2016. Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: Analysis of real-life data from the DPV registry from Germany and Austria. Diabetes Research and Clinical Practice, 115, S.31-8.

      • Dalos, D., Gangl, C., Roth, C., Krenn, L., Scherzer, S., Vertesich, M., Lang, I., Maurer, G., Neunteufl, T., Berger, R. & Delle-Karth, G., 2016. Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent. BMC Cardiovascular Disorders, 16, S.104.

      • Geltner, C., Errhalt, P., Baumgartner, B., Ambrosch, G., Machan, B., Eckmayr, J., Klikovits, T., Hoda, M.Alireza, Popper, H. & Klepetko, W., 2016. Management of malignant pleural mesothelioma – Part 1: epidemiology, diagnosis, and staging. Wiener klinische Wochenschrift, 128, S.611-617.

      • Gennaro, G., Brener, S.J., Redfors, B., Kirtane, A.J., Genereux, P., Maehara, A., Neunteufl, T., Metzger, D.C., Mehran, R., Gibson, C.M. & Stone, G.W., 2016. Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial). American Journal of Cardiology, 118, S.1097-1104.

      • Gohl, O., Walker, D.J., Walterspacher, S., Langer, D., Spengler, C.M., Wanke, T., Petrovic, M., Zwick, R.Harun, Stieglitz, S., Glockl, R., Dellweg, D. & Kabitz, H.J., 2016. Atemmuskeltraining: State-of-the-Art. Pneumologie, 70(1), S.37-48.

      • Grave, M.S., Sterz, F., Nurnberger, A., Fykatas, S., Gatterbauer, M., Stattermayer, A.F., Zajicek, A., Malzer, R., Sebald, D. & van Tulder, R.Henricus, 2016. Safety and feasibility of the RhinoChill immediate transnasal evaporative cooling device during out-of-hospital cardiopulmonary resuscitation: A single-center, observational study. Medicine, 95, S.e4692.

      • Greil, R., Obrtlikova, P., Smolej, L., Kozak, T., Steurer, M., Andel, J., Burgstaller, S., Mikuskova, E., Gercheva, L., Nosslinger, T., Papajik, T., Ladicka, M., Girschikofsky, M., Hrubisko, M., Jager, U., Fridrik, M., Pecherstorfer, M., Kralikova, E., Burcoveanu, C., Spasov, E., Petzer, A., Mihaylov, G., Raynov, J., Oexle, H., Zabernigg, A., Flochova, E., Palasthy, S., Stehlikova, O., Doubek, M., Altenhofer, P., Pleyer, L., Melchardt, T., Klingler, A., Mayer, J. & Egle, A., 2016. Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial. The Lancet Haematology, 3, S.e317-29.

      • Hackner, K., Errhalt, P., Mueller, M.Rolf, Speiser, M., Marzluf, B.A., Schulheim, A., Schenk, P., Bilek, J. & Doll, T., 2016. Canine scent detection for the diagnosis of lung cancer in a screening-like situation. Journal of Breath Research, 10, S.046003.

      • Hoda, M.A., Klikovits, T., Arns, M., Dieckmann, K., Zochbauer-Muller, S., Geltner, C., Baumgartner, B., Errhalt, P., Machan, B., Pohl, W., Hutter, J., Eckmayr, J., Studnicka, M., Flicker, M., Cerkl, P. & Klepetko, W., 2016. Management of malignant pleural mesothelioma – Part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG). Wiener klinische Wochenschrift, 128, S.618-26.

      • Kettenbach, J., Mittendorfer, M., Wimmer, I., Mader, M., Taubenschuss, E., Unfried, E. & Heinz, G., 2016. Transgastric biopsy of a submucosal gastric tumour. BJR Case Reports, 2, S.20160009.

      • Klikovits, T., Hoda, M.A., Dong, Y., Arns, M., Baumgartner, B., Errhalt, P., Geltner, C., Machan, B., Pohl, W., Hutter, J., Eckmayr, J., Studnicka, M., Flicker, M., Cerkl, P., Kirchbacher, K. & Klepetko, W., 2016. Management of malignant pleural mesothelioma – Part 3: Data from the Austrian Mesothelioma Interest Group (AMIG) database. Wiener klinische Wochenschrift, 128, S.627-34.

      • Kussmann, M., Schuster, L., Wrenger, S., Pichler, P., Reznicek, G., Burgmann, H., Poeppl, W., Zeitlinger, M. & Wiesholzer, M., 2016. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli. Peritoneal Dialysis International, 36, S.662-668.

      • Lammerich, A., Balcke, P., Bias, P., Mangold, S. & Wiesholzer, M., 2016. Cardiovascular Morbidity and Pure Red Cell Aplasia Associated With Epoetin Theta Therapy in Patients With Chronic Kidney Disease: A Prospective, Noninterventional, Multicenter Cohort Study. Clinical Therapeutics, 38, S.276-287 e4.

      • Moser, M., Wiedemann, D., Kitzwögerer, M. & Frank, H., 2016. Adenocarcinoma of the ampulla of Vater metastasising into the right ventricle. BMJ Case Reports, 2016.

      • Roth, C., Berger, R., Scherzer, S., Krenn, L., Gangl, C., Dalos, D., Delle-Karth, G. & Neunteufl, T., 2016. Comparison of magnetic wire navigation with the conventional wire technique for percutaneous coronary intervention of chronic total occlusions: a randomised, controlled study. Heart and vessels, 31(8), S.1266-76.

      • Roth, C., Berger, R., Scherzer, S., Krenn, L., Gangl, C., Dalos, D., Delle-Karth, G. & Neunteufl, T., 2016. Comparison of magnetic wire navigation with the conventional wire technique for percutaneous coronary intervention of chronic total occlusions: a randomised, controlled study. Heart and Vessels, 31, S.1266-76.

      • Roth, C., Gangl, C., Dalos, D., Krenn, L., Scherzer, S., Gerken, A., Reinwein, M., Zhang, C., Hagmann, M., Wrba, T., Delle-Karth, G., Neunteufl, T., Maurer, G., Vock, P., Mayr, H., Frey, B. & Berger, R., 2016. Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy. PLoS One, 11, S.e0154025.

      • Schur, S., Weixler, D., Gabl, C., Kreye, G., Likar, R., Masel, E.K., Mayrhofer, M., Reiner, F., Schmidmayr, B., Kirchheiner, K. & Watzke, H.H., 2016. Sedation at the end of life - a nation-wide study in palliative care units in Austria. BMC Palliative Care, 15, S.50.

      • Wagner, G., Moertl, D., Eckhardt, A., Sagel, U., Wrba, F., Dam, K. & Willinger, B., 2016. Chronic Paracoccidioidomycosis with adrenal involvement mimicking tuberculosis - A case report from Austria. Medical Mycology Case Reports, 14, S.12-16.

      • Wiesholzer, M., Pichler, P., Reznicek, G., Wimmer, M., Kussmann, M., Balcke, P., Burgmann, H., Zeitlinger, M. & Poeppl, W., 2016. An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis. Antimicrobial Agents and Chemotherapy, 60, S.2790-7.

      • Zwickl, H., Zwickl-Traxler, E. & Pecherstorfer, M., 2016. A single-center retrospective analysis of first-line therapy of multiple myeloma with bendamustine-bortezomib-dexamethasone. Leukemia & Lymphoma, 57, S.2065-70.

  6. 2015

    • Zeitschriftenartikel

      • Duck, A., Pigram, L., Errhalt, P., Ahmed, D. & Chaudhuri, N., 2015. IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe. Advances in Therapy, 32, S.87-107.

      • Errhalt, P., 2015. Idiopathische Pulmonale Fibrose - ein Update. Journal für Pneumologie, 3, S.11-17.

      • Geltner, C. & Errhalt, P., 2015. Malignant pleural effusion: pathogenesis, diagnosis, and management. memo - Magazine of European Medical Oncology, 8, S.235-241.

      • Grabner, B., Schramek, D., Mueller, K.M., Moll, H.P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., Stiedl, P., Nivarthi, H., Bogner, E., Gruber, W., Mohr, T., Zwick, R.Harun, Kenner, L., Poli, V., Aberger, F., Stoiber-Sakaguchi, D., Egger, G., Esterbauer, H., Zuber, J., Moriggl, R., Eferl, R., Gyorffy, B., Penninger, J.M., Popper, H. & Casanova, E., 2015. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nature Communications, 6, S.6285.

      • Kussmann, M., Schuster, L., Zeitlinger, M., Pichler, P., Reznicek, G., Wiesholzer, M., Burgmann, H. & Poeppl, W., 2015. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis. European Journal of Clinical Microbiology & Infectious Diseases, 34, S.2257-63.

      • Lamprecht, B., Mikes, R., Aigner, K., Auer, W., Bolitschek, J., Errhalt, P., Fazekas, A., Flick, H., Funk, G.-C. & Haider, A., 2015. Abstracts Jahrestagung 2015 der Österreichischen Gesellschaft für Pneumologie. Wiener klinische Wochenschrift, 127, S.803-839.

      • Sandhofer, M.J., Salzer, H. & Kulnig, J., 2015. Foreign body aspiration - Sometimes a tough nut to crack. Respiratory Medicine Case Reports, 15, S.18-9.

      • Stadlbauer, A., Pichler, P., Karl, M., Brandner, S., Lerch, C., Renner, B. & Heinz, G., 2015. Quantification of serial changes in cerebral blood volume and metabolism in patients with recurrent glioblastoma undergoing antiangiogenic therapy. European journal of radiology, 84(6), S.1128-36.

      • van Tulder, R.Henricus, Laggner, R., Kienbacher, C., Schmid, B., Zajicek, A., Haidvogel, J., Sebald, D., Laggner, A.N., Herkner, H., Sterz, F. & Eisenburger, P., 2015. The capability of professional- and lay-rescuers to estimate the chest compression-depth target: a short, randomized experiment. Resuscitation, 89, S.137-41.

      • Wimmer, I., Minear, G., Brustbauer, R., Götzinger, P. & Dam, K., 2015. Pancreatic VIPoma visualized by 68Ga DOTA-NOC PET-CT. Nuklearmedizin, 54, S.N32-3.

      • Wollmann, C.Georg, Gradaus, R., Bocker, D., Fetsch, T., Hintringer, F., Hoh, G., Hatala, R., Podczeck-Schweighofer, A., Kreutzer, U., Kamaryt, P., Hauser, T., Kersten, J.F., Wegscheider, K. & Breithardt, G., 2015. Variations of heart rate variability parameters prior to the onset of ventricular tachyarrhythmia and sinus tachycardia in ICD patients. Results from the heart rate variability analysis with automated ICDs (HAWAI) registry. Physiological Measurement, 36, S.1047-61.

      • Wollmann, C.Georg, Steiner, E., Kleinjung, F. & Mayr, H., 2015. A detailed view on pacemaker lead parameters remotely transmitted after magnetic resonance. Pacing and Clinical Electrophysiology, 38, S.746-57.

      • Zwick, R.Harun & Lichtenschopf, A., 2015. Geschichte der pneumologischen Rehabilitation und der Status quo in Österreich. Pneumologie, 69(9), S.545-8.

  7. 2014

    • Zeitschriftenartikel

      • Erbel, R., Aboyans, V., Boileau, C., Bossone, E., Di Bartolomeo, R., Eggebrecht, H., Evangelista, A., Falk, V., Frank, H., Gaemperli, O., Grabenwoger, M., Haverich, A., Iung, B., Manolis, A.J., Meijboom, F., Nienaber, C.A., Roffi, M., Rousseau, H., Sechtem, U., Sirnes, P.A., von Allmen, R.S. & Vrints, C.J., 2014. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Polish Heart Journal, 72, S.1169-252.

      • Kopec, G., Moertl, D., Miszalski-Jamka, T., Waligora, M., Tyrka, A., Sarnecka, A. & Podolec, P., 2014. Left ventricular mass is preserved in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. Heart, Lung and Circulation, 23, S.454-61.

      • Oberndorfer, S., Ungersboeck, K., Moser, W., Riedlberger, U., Marhold, F., Heinz, G., Sedivy, R., Brustbauer, R., Kopetzky, G., Vyhnalik, M. & Balcke, P., 2014. Interdisziplinäre neuroonkologische Betreuung eines Patienten mit sekundärem Gliobalstom. Tumorboard, 3, S.13-16.

      • Poelzl, G., Altenberger, J., Pacher, R., Ebner, C.H., Wieser, M., Winter, A., Fruhwald, F., Dornaus, C., Ehmsen, U., Reiter, S., Steinacher, R., Huelsmann, M., Eder, V., Böhmer, A., Pilgersdorfer, L., Ablasser, K., Keroe, D., Groebner, H., Auer, J., Jakl, G., Hallas, A., Ess, M., Ulmer, H. & Heart, F.Austrian W., 2014. Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure. International Journal of Cardiology, 175, S.83-9.

      • Schilling, M., Sailer, A.S., Heinz, G. & Kutilek, M., 2014. Intrathorakale Perforation von Gallenwegsstents bei St. p. Lebertransplantation. Röfo, 186, S.887-8.

      • Teischinger, L., Plass, C., Mayr, H. & Frey, B., 2014. A wide QRS complex tachycardia: what is the mechanism?. Heart Rhythm, 11, S.1079-81.

      • Troughton, R.W., Frampton, C.M., La Rocca, H.P.Brunner, Pfisterer, M., Eurlings, L.W., Erntell, H., Persson, H., O'Connor, C.M., Moertl, D., Karlstrom, P., Dahlstrom, U., Gaggin, H.K., Januzzi, J.L., Berger, R., Richards, A.M., Pinto, Y.M. & Nicholls, M.G., 2014. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. European Heart Journal, 35, S.1559-67.

      • Uitz, E., Bahadori, B., McCarty, M.F. & Moghadasian, M.H., 2014. Practical strategies for modulating foam cell formation and behavior. World Journal of Clinical Cases, 2, S.497-506.

      • Wimmer, I., Hartmann, T., Brustbauer, R., Minear, G. & Dam, K., 2014. Selenium levels in patients with autoimmune thyroiditis and controls in lower Austria. Hormone and Metabolic Research, 46, S.707-9.

      • Woehrer, A., Hackl, M., Waldhor, T., Weis, S., Pichler, J., Olschowski, A., Buchroithner, J., Maier, H., Stockhammer, G., Thome, C., Haybaeck, J., Payer, F., von Campe, G., Kiefer, A., Wurtz, F., Vince, G.H., Sedivy, R., Oberndorfer, S., Marhold, F., Bordihn, K., Stiglbauer, W., Gruber-Mosenbacher, U., Bauer, R., Feichtinger, J., Reiner-Concin, A., Grisold, W., Marosi, C., Preusser, M., Dieckmann, K., Slavc, I., Gatterbauer, B., Widhalm, G., Haberler, C. & Hainfellner, J.A., 2014. Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry. British Journal of Cancer, 110, S.286-96.

      • Wollmann, C.Georg, 2014. Reel syndrome in an ICD with DF4 connector. Herzschrittmachertherapie + Elektrophysiologie, 25, S.206-8.

      • Wollmann, C.Georg, Lawo, T., Kuhlkamp, V., Becker, R., Garutti, C., Jackson, T., Brown, M.L. & Mayr, H., 2014. Implantable defibrillators with enhanced detection algorithms: detection performance and safety results from the PainFree SST study. Pacing and Clinical Electrophysiology, 37, S.1198-209.

      • Zweiker, D., Maier, R., Lamm, G., Maurer, E., Heigert, M., Neunteufl, T., Zeindlhofer, E., Grund, M., Aichinger, J., Huber, K., Schneider, J., Pollak, J., Luha, O. & Zweiker, R., 2014. The Austrian transcatheter aortic valve implantation (TAVI) Registry--3 years' data. International Journal of Cardiology, 177, S.114-6.

Events

  1. 07 Okt

    Ringvorlesung: Gender matters!

    07. Oktober 2020, 18:00 - 22:00
    Auditorium der Karl Landsteiner Privatuniversität für Gesundheitswissenschaften
  2. 21 Okt

    Ringvorlesung: Gender Medicine

    21. Oktober 2020, 18:00 - 22:00
    Auditorium der Karl Landsteiner Privatuniversität für Gesundheitswissenschaften
  3. 05 Nov

    Ringvorlesung: Neurologische Rehabilitation

    05. November 2020, 18:00 - 22:00
    Auditorium der Karl Landsteiner Privatuniversität für Gesundheitswissenschaften